Search results :

Cytarabine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: L01BC01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Conjunctivitis 80% x x x x x x x x
Arachnoiditis 16% - 42.4% x x x x x x x
Headache 2% - 56.4% x x x x x x x x x x x x x x
Fatigue 6% - 46.4% x x x x
Body temperature increased 0% - 45.5% x x x x x x x x x x x x x x
Gait disturbance 1% - 29% x x x x x x
Dizziness 18% - 21.4% x x x x x x x x x x x
Diarrhoea 11% - 32.1% x x x x x x x x x x x x
Asthenia 5% - 53.6% x x x x x x
Insomnia 13.6% - 25% x x x
Nausea 0% - 53.6% x x x x x x x x x x x x x x
Vomiting 2% - 43.6% x x x x x x x x x x x x x x
Urinary tract infection 13.6% - 18.2% x x x
Pain in extremity 12.1% - 28.6% x x x
Tremor 8.56% - 18% x x x x
Back pain 0% - 23.7% x x x x x x x
Abdominal pain 8.56% - 15.2% x x x x x x x x x x x
Depression 8.17% - 18.2% x x x
Lethargy 12.1% - 16% x x x
Convulsion 1% - 22% x x x x x x x
Dehydration 10.7% - 18.2% x x x
Neck pain 4% - 15.2% x x x x x x
Dyspnoea 9.73% - 21.4% x x x x x x x x x x x
Anaemia 1% - 18.2% x x x x x x x x x x x x x
Memory impairment 3.57% - 14% x x x
Arthralgia 9.09% - 14.3% x x x
Decreased appetite 10.7% - 12.1% x x x
Vision blurred 11% - 14.3% x x x x x
Confusional state 2% - 36.4% x x x x x x x
Constipation 0% - 25% x x x x x
Neutropenia 8% - 36.4% x x x x x x
Thrombocytopenia 5% - 32.1% x x x x x x x x x x x x x x
Hypoaesthesia 2% - 12.1% x x x x x x
Hearing impaired 5.84% - 18.2% x x x
Oedema peripheral 0% - 25% x x x x x
Agitation 7.14% - 15.2% x x x
Pain 0% - 20% x x x x x x x x
Muscular weakness 7.14% - 15.2% x x x x
Cough 6.61% - 21.4% x x x x
Dysphagia 7.78% - 10.7% x x x
Incontinence 7.39% - 17.9% x x x x
Neuropathy 2.72% - 11% x x x x x x x x x x x
Neurotoxicity 8-10% x x x x
Tachycardia 0% - 17.9% x x x
Neck stiffness 1.28% - 14.3% x x x x x x x
Hypotension 7.14% - 18.2% x x x
Hyperglycaemia 5.84% - 12.1% x x x
Hypokalaemia 6.61% - 15.2% x x x x
Mucosal inflammation 3.11% - 12.1% x x x x
Hyponatraemia 3.57% - 12.1% x x x
Anxiety 3.03% - 10.7% x x x
Pneumonia 6.06% - 10.7% x x x x x x x x x x x
Peripheral sensory neuropathy 2.72% - 11% x x x
Hypertension 3.57% - 15.2% x x x
Anorexia 3.03% - 17.9% x x x x x x x x x x x
Urinary retention 0% - 10.7% x x x x x x x x x x x
Neuropathy peripheral 3.5% - 12.1% x x x x
Somnolence 2% - 12% x x x x x x x x x x x
Haemorrhoids 0% - 10.7% x x x
Platelet count decreased 0% - 10.7% x x x
Syncope 0% - 11% x x x
Contusion 2.33% - 10.7% x x x
Oedema 2.33% - 21.4% x x x
Diffuse large B-cell lymphoma 0.389% - 10.7% x x x
Sweating increased 2.33% - 10.7% x x x
Deafness 3% x
Numbness 3% x
Paraesthesia 3% x x
Spinal cord disorder 3% x
Cranial nerve paralysis 3% x
Cauda equina syndrome 3% x
Reflexes abnormal 0% - 11% x x x
Pruritus 0% - 14.3% x x x x x x x x x x x
Hydrocephalus 2% x
Urinary incontinence 0% - 11% x x x
Hemiplegia 1% x
Altered state of consciousness 1% x
Blindness 1% x x x x
Meningism 1% x x x x x x x
Cardio-respiratory arrest 1% x x
Alopecia x x x x x x x x
Anaphylactic shock x x x x x x x x
Anaemia megaloblastic x
Mental disorder x x x x
Cellulitis x x x x x x
Cerebellar syndrome x x x x x x x x
Chest pain x x x x x x x x
Coma x x x x x x x
Infection x x x x x x x x x x x
Connective tissue disorder x x x x
Cyst x x x
Oesophagitis x x x x x x x x
Rash x x x x x x x x
Extravasation x
Eye disorder x x x x x
Ephelides x x x x x x x x
Gastrointestinal disorder x x x x x
Gastrointestinal haemorrhage x
Guillain-Barre syndrome x
Cardiac disorder x x x x
Cardiomegaly x x x x x x x
Blood disorder x x x
Haemorrhage x x x x x x x x
Hyperbilirubinaemia x x x x x x x
Hypersensitivity x
Hypocalcaemia x
Immune status x x x x x x x
Immune system disorder x
Inflammation x x
Unspecified disorder of intestine x
Jaundice x x x x x x x
Keratitis x
Renal failure acute x
Leukopenia x x x x x x x x
Liver abscess x x x x x x x x
Mediastinal disorder x x x x
Meningitis x
Nervous system disorder x x x x x x x x x x x
Neuritis x x x x x x x
Pancreatitis x x x x x x x x
Paraplegia x x x
Pericarditis x x x x x x x x
Peritonitis x x x x x x x x
Pneumatosis cystoides intestinalis x x x x x x x x
Polyp x x x
Psychotic disorder x
Pulmonary oedema x x x x x x x x
Acute respiratory distress syndrome x x
Rhabdomyolysis x
Skin ulcer x x x x x x x x
Spastic paraparesis x
Thrombophlebitis x x x x x x x x
Tumour lysis syndrome x
Ulcer x x x x x x x x
Ureteric obstruction x
Urinary tract disorder x x x x x
Urticaria x x x x x x x
Angiopathy x x x x
Weight increased x
Hypoalgesia x
Photophobia x x
Hepatic function abnormal x x x x x x x x
Amylase increased x
Injection site reaction x x
Hepatocellular injury x x x x x x x
Bone pain x x x x x x x x
Eye pain x x
Oesophageal ulcer x x x x x x x
Liver injury x
Malnutrition x x x x x
Intestinal infections x
Unspecified disorder of skin and subcutaneous tissue x x x x
Interstitial pneumonia x x x x x x x x
Fatal outcomes x
Malaise x x x x x x x x
Myalgia x x x x x x x x
Tachypnoea x
Neurological symptom x
Skin exfoliation x x x x x x x x
Anal inflammation x x x x x x x
Personality change x x x x x x x x
Throat sore x x x x x x x x
Disease progression x x
Sepsis x x x x x x x x
Cerebral dysfunction x
Hepatobiliary disease x
Leukoencephalopathy x x
Hydrocephalus acquired x x x
Blood bilirubin increased x
Cognitive impairment x
Capillary leak syndrome x
Lacrimation x x
Sensation of foreign body x x
Rash maculo-papular x x x x x x x x
Transaminases increased x
Respiratory distress x x x x x x x
Neurological impairment x
Visual disturbance x
Lipase increased x
Hypoxemia x
Infectious meningitis x x
Hyperuricaemia x
Febrile neutropenia x
Memory loss x
Allergic oedema x x x x x x x
Infestation NOS x x x x x
Blood and lymphatic system disorders x x
Ear and labyrinth disorders x x x x
Myelosuppression x
Cardiotoxicity x x x x x
Cardiomyopathy x x x x x x x x
Pulmonary toxicity x x x x x x x
Venoocclusive disease x
Necrotising colitis x x x x x x x x
Ileus x
Ocular toxicity x
Urine output x
Vasculitis necrotising x
Cytarabine syndrome x x x x x x x x
Intestinal necrosis x x x x x x x x
CNS toxicity x
Non-cardiogenic pulmonary oedema x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CYTARABINE / DEPOCYT

Side effects:22
Source:FDA

CYTARABINE / DEPOCYT

Side effects:25
Source:Health Canada

cytarabine / cytarabine

Side effects:45
Source:EMA

CYTARABINE

Side effects:82
Source:FDA Structured Product Label

cytarabine liposome injection / DepoCyt

Side effects:83
Source:FDA

CYTARABINE / DEPOCYT

Side effects:83
Source:FDA

CYTARABINE

Side effects:65
Source:FDA Structured Product Label

CYTARABINE

Side effects:65
Source:FDA Structured Product Label

CYTARABINE

Side effects:66
Source:FDA Structured Product Label

CYTARABINE

Side effects:66
Source:FDA Structured Product Label

CYTARABINE

Side effects:66
Source:FDA Structured Product Label

CYTARABINE / CYTOSAR 100 MG

Side effects:77
Source:Health Canada

Cytarabine

Side effects:117
Source:BC Cancer

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label